Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulationAn analytical resource of post-translational modifications from over 1,000 patients across 11 cancer types reveals pan-cancer changes involved in hallmark cancer processes and reveals potential new therapeutic avenues.An analytical resource of post-translational modifications from over 1,000 patients across 11 cancer types reveals pan-cancer changes involved in hallmark cancer processes and reveals potential new therapeutic avenues.Yifat Geffen, Shankara Anand, Yo Akiyama, Tomer M. Yaron, Yizhe Song, Jared L. Johnson, Akshay Govindan, Özgün Babur, Yize Li, Emily Huntsman, Liang-Bo Wang, Chet Birger, David I. Heiman, Qing Zhang, Mendy Miller, Yosef E. Maruvka, Nicholas J. Haradhvala, Anna Calinawan, Saveliy Belkin, Alexander Kerelsky, Karl R. Clauser, Karsten Krug, Shankha Satpathy, Samuel H. Payne, D.R. Mani, Michael A. Gillette, Saravana M. Dhanasekaran, Mathangi Thiagarajan, Mehdi Mesri, Henry Rodriguez, Ana I. Robles, Steven A. Carr, Alexander J. Lazar, François Aguet, Lewis C. Cantley, Li Ding, Gad Getz, Clinical Proteomic Tumor Analysis Consortiumhttps://www.cell.com/cell/fulltext/S0092-8674(23)00781-X?rss=yeshttp://www.cell.com/cell/inpress.rssCellCell RSS feed.Wireless News CampaignAugust 15, 2023

Powered by WPeMatico